CN Patent

CN117860708A — 含有普拉克索和雷沙吉兰的透皮贴片

Assigned to Individual · Expires 2024-04-12 · 2y expired

What this patent protects

本发明涉及一种透皮贴片，由背衬膜、粘合剂基质和离型膜组成。粘合剂基质中含有两种活性药物成分，普拉克索和雷沙吉兰。该透皮贴片用于在7天内粘贴在皮肤上，以递送普拉克索和雷沙吉兰，用于治疗帕金森病。

USPTO Abstract

本发明涉及一种透皮贴片，由背衬膜、粘合剂基质和离型膜组成。粘合剂基质中含有两种活性药物成分，普拉克索和雷沙吉兰。该透皮贴片用于在7天内粘贴在皮肤上，以递送普拉克索和雷沙吉兰，用于治疗帕金森病。

Drugs covered by this patent

Patent Metadata

Patent number
CN117860708A
Jurisdiction
CN
Classification
—
Expires
2024-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.